Non-Current Assets

Indefinite-Lived Intangible Assets

Gilead Sciences Indefinite-Lived Intangible Assets remained flat by 0.0% to $2.30B in Q1 2026 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryMarket Position
SignalHigher is better
VolatilityStable
First reportedQ4 2025
Last reportedQ1 2026

How to read this metric

Stability or growth indicates the sustained value of the company's brand or core intellectual property.

Detailed definition

These are intangible assets, such as brand names or certain licenses, that are expected to provide value for an unlimite...

Peer comparison

Standard for companies with strong brand equity or long-term regulatory licenses.

Metric ID: indefinite_lived_intangible_assets

Historical Data

2 periods
 Q4 '25Q1 '26
Value$2.30B$2.30B
QoQ Change—+0.0%
Range$2.30B – $2.30B

Indefinite-Lived Intangible Assets at Other Companies

AbbVie logo
AbbVieABBVView metric
Pfizer logo
PfizerPFEView metric

Frequently Asked Questions

What is Gilead Sciences's indefinite-lived intangible assets?
Gilead Sciences (GILD) reported indefinite-lived intangible assets of $2.30B in Q1 2026.
What does indefinite-lived intangible assets mean?
Intangible assets like brands that are expected to last forever and are not depreciated.